Kevin Church is CHIEF SCIENTIFIC OFFICER of Athira Pharma, Inc.. Currently has a direct ownership of 20,681 shares of ATHA, which is worth approximately $95,339. The most recent transaction as insider was on Jun 08, 2021, when has been sold 3,152 shares (Common Stock) at a price of $1.04 per share, resulting in proceeds of $3,278. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 20.7K
87.76% 3M change
84.18% 12M change
Total Value Held $95,339

KEVIN CHURCH Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 08 2021
BUY
Exercise of conversion of derivative security
$3,278 $1.04 p/Share
3,152 Added 6.67%
44,133 Common Stock
KC

Kevin Church

CHIEF SCIENTIFIC OFFICER
Bothell, WA

Track Institutional and Insider Activities on ATHA

Follow Athira Pharma, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ATHA shares.

Notify only if

Insider Trading

Get notified when an Athira Pharma, Inc. insider buys or sells ATHA shares.

Notify only if

News

Receive news related to Athira Pharma, Inc.

Track Activities on ATHA